Skip to main content

Market Overview

Mirum Pharmaceuticals to Present at Upcoming Investor Conferences

Share:

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that the company will participate in the following upcoming virtual investor conferences:

SVB Leerink 10th Annual Global Healthcare Conference

Friday, February 26, 2021 at 3:40 p.m. ET

Raymond James Virtual Institutional Investors Conference

Wednesday, March 3, 2021 at 3:00 p.m. ET

H.C. Wainwright Global Life Sciences Conference

The presentation will be available for viewing on Tuesday, March 9, 2021 at 7:00 a.m. ET.

Oppenheimer 31st Annual Healthcare Conference

Wednesday, March 17, 2021 at 4:30 p.m. ET

The audio webcasts, on-demand presentation, and an archive of all presentations will be available in the Investors & Media section of Mirum's website at ir.mirumpharma.com.

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Mirum's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. Mirum has submitted an NDA for maralixibat in the treatment of cholestatic pruritus in patients with ALGS. Additionally, Mirum's marketing authorization application for the treatment of pediatric patients with PFIC2 has been accepted for review (validated) by the European Medicines Agency.

Mirum is also developing volixibat, also an oral ASBT-inhibitor, in primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, and primary biliary cholangitis. For more information, visit MirumPharma.com.

Follow Mirum on Twitter, Facebook, LinkedIn and Instagram.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com